 | Kintara Therapeutics, Inc. | |||
| NCM : KTRA || Location: United States | ||||
$0.16-0.0 (-1.52%) |
43.41 M | 0.15 - 0.19 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.700 M |
| March 28, 2024 | 0.659 M |
| March 15, 2024 | 2.197 M |
| Feb. 29, 2024 | 2.192 M |
| Feb. 15, 2024 | 0.411 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.59 | -1.83 | -209.33% |
| 06/30/2023 | -1.08 | -1.95 | -81.21% |
| 03/31/2023 | -0.19 | -1.94 | -901.03% |
| 12/31/2022 | -3.23 | -2.10 | 34.95% |
| 06/30/2022 | -1.50 | -5.50 | -266.70% |
KTRA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 39.038M | Shares Float | 39.030M |
| Short Float | 0.700M | Market Cap | 6.25M |
| Institution ownership | 0.57% | Insider ownership | 0.195% |
| Earnings Date | 05/15/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -5.22 | Forward EPS | -0.38 |